The California-based genome informatics company offers a proprietary, automated genomic interpretation platform that allows clinical laboratories to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Cypher Genomics' software solutions, MantisTM and CoralTM, improve diagnostic accuracy and earlier interventions, optimize therapeutic approaches, and reduce adverse drug reactions. The company's proprietary ranking algorithm is more effective at disease variant identification compared to other methodologies.